Problem Penegakkan Diagnostik Pasien dengan Massa di Paru

Laksmi Wulandari, Nikson Eduard Faot

Abstract views = 534 times | downloads = 6227 times


Background: Lung cancer are divided into 2 groups; i.e. Small cell lung cancer (SCLC) and non-small cell lung cancer (NSCLC). About 30% of NSCLC is squamus cell carcinoma and the other is adeno carcinoma. Late diagnosis makes such a high mortality rate. Early diagnosis plays a very important role in the management of therapy. Case: Patients complain of chronic cough more than 6 months, decreased appetite and weight loss. Chest X-ray and CT scan show a density of round shape mass, with firm border and smooth regular edge, also lympnodes enlargement (T2N2Mx) stage IIb. Appearance of lung mass is benign according to clinically and radiologically. FNAB-CT Guiding results are difference each time examination. The first result is squamous cell carcinoma but the last result is teratoma. Discussion: Based on the multidisciplinary discussion on Tumor Board Meeting, the diagnosis was decide as Squamous cell Carcinoma. The choice management of stage IIb lung cancer is surgery (Lobectomy). Histopathology finding post surgery is a Squamus Cell Carcinoma. Patients were then given adjuvant chemotherapy for 4 cycles with Platinum Base regimen paxuscarboplatin with the aim of clearing micrometastase that may still be left behind. The complete respons of platinum based chemotherapy following surgery in early stage of squamous cell carcinoma. Conclusion: Difficulties of lung cancer diagnostic are still the problem in the management of lung mass. Difference of diagnostic makes difference treatment choice. Multidiscipline discussion is needed to decide the diagnostic and treatment judgment.


Diagnostic, Lung mass, Squamus Cell Carcinoma, Surgery, Chemotherapy

Full Text:



Mountain F Clifton, Hermes E Kay. Cancer Imaging: Lung and Breast Carcinomas. In Hayat MA, editor. The Role of Imaging in Lung Cancer. Union, New Jersey: Elsevier Academic Press; 2008 Elsevier Inc.

Gazdar, Ignacio I. Wistuba,F Adi. Characteristic genetic alterations in lung cancer. In driscoll b, editor. lung cancer Molecular Pathology. 1st ed. totowa: humana press; 2006.

G. Buccheri, D. Ferrigno. Lung cancer: Clinical presentation and specialist referral time. European Respiratory Journal. 2004;(24): p. 898–904.

Schreiber Gilbert, Douglas C. McCrory. Performance characteristics of different modalities for diagnosis suspected lung cancer. chest journal. 2003;(1): p. 123.

Kwun M. Fong, Yoshitaka Sekido, Minna D Jhon. Molecular pathogenesis of lung cancer. Ann Thorac Cardiovasc Surgery. 1999;(118): p. 1136–52.

Wallace T.Miller, Jr. Diagnostic thoracic imaging. 1st ed. pennsylvania: McGraw-hill; 2006.

Clifton F. Mountain, Kay E. Hermes. Cancer Imaging: Lung and Breast Carcinomas. In Hayat MA, editor. The Role of Imaging in Lung Cancer. Union, New Jersey: Elsevier Academic Press; 2008 Elsevier Inc.

Erasmus F Jeremy,Jhon E connolly, H page Mcadam, et al. Solitary pulmonary nodules: Part I. morphologic evaluation for difrrentiation of benIgn and malignant lessions. Radiographics. 2000;(20): p. 43–58.

Yunus Anwar, Syahrudin Elisna, Wibawanta Agung, et al. kanker paru jenis karsinoma bukan sel kecil. Revisi ed. Elisna Syahrudin AJ, editor. indonesia: PDPI; 2011.

Lardinois Didier, Weder Walter, Thomas F. et al. Staging of non– small-cell lung cancer with integrated positron-emission tomography and computed tomography. The new england journal of medicine. 2003;(348): p. 2500–2507.

Erasmus Jeremy F, Connolly Jhon E, Mcadam H page, et al. Solitary pulmonary nodules : Part II. evaluation of the inderterminate nodule. radiographics. 2000;(20): p. 59–66.

Erozan Yener S, Ramzy Ibrahim. Pulmonary Cytopathology. In Ali SZ, editor. Essentials In cytopathology series. Baltimore, Maryland: springer; 2009.

Mondal Kumar Santosh, Senjuti DasGupta. Mature cystic teratoma of the lung. Singapore Med J. 2012;(11): p. 237–239.

Zenker Dieter, Aleksic Ivan. Intrapulmonary cystic benign teratoma :A case report and review of the literature. Ann Thorac Cardiovasc Surg. 2004;(10): p. 290–292.

S Sandeep. Rana, Naveen Swami, et al. Intrapulmonary teratoma. Ann Thorac Cardiovasc Surg. 2007;(83): p. 1194–1196

Mi-Young Jeung, Gasser Bernard, Afshin Gangi, et al. Imaging of cystic masses of the mediastinum. Radiographics. 2002;(22): p. 79–93.

Sergi Juanpere,Noemi Canete, Pedro Ortuno et al. A diagnostic approach to the mediastinal masses. Insights Imaging. 2013;(4): p. 29–52.

Roy S. Herbst, John V. Heymach,Scott M. Lippman. Lung Cancer. The new england journal o f medicine. 2008;(359): p. 1367-1380.

Moreno Pablo Perez, Brambilla Elisabeth, Roman Thomas, et al. Squamous cell carcinoma of the lung therapeutic opportunities. Clin Cancer Res. 2012d;(18): p. 2443–2451.

Wilkerson Matthew D., Xiaoying Yin, Katherine A. Hoadley, et al. Lung Squamous Cell Carcinoma mRNA Expression Subtypes Are Reproducible, Clinically Important, and Correspond to Normal Cell Types. Clin Cancer Res. 2010;(16): p. 4864–4875.

Heon Stephanie, Johnson Bruce E.. Adjuvant chemotherapy for surgically resected non–small cell lung. Journal Thorac Cardiovasc Surgery. 2012;(144): p. 39–42.

Sandler Alan,,Michael Robert Gray C. Perry, et al. Paclitaxel– carboplatin alone or with bevacizumab for non–small cell lung cancer. The new england journal of medicine. 2006;(355): p. 2542-2550.

Deslauriers J. Current surgical treatment of nonsmall cell lung cancer. Eur Respir J. 2002; 19(35): p. 61–70

Keller Steven M, Sudeshna Adak, Henry Wagner, Arnold Herkovic. A randomized trial of postoperative adjuvant therapy in patient with completely resected stage II or IIIA non-small cell lung cancer. The New England Journal of Medicine. 2000; 343(17): p. 1217–1222.

Gold, Ignacio I. Wistuba, Edward S. Kim. New strategies in squamous cell carcinoma of the lung: Identification of tumor drivers to personalize therapy. Clin Cancer Res. 2012;(18): p. 3002–3007.

Strauss Gary M., James E. Herndon II, Michael A. Maddaus, et al. Adjuvant paclitaxel plus carboplatin compared with observation in stage IB non–small-cell lung cancer: CALGB 9633 With the cancer and leukemia group B, radiation therapy oncology Group, and North Central Cancer Treatment Group Study Groups. Journal Of Clinical Oncology. 2008;(26): p. 5043–5051.

Reungwetwattana Thanyanan, Eadens. Matthew J. Chemotherapy for non-small-cell lung carcinoma: from a blanket approach to individual therapy. Respiratory Criticall Care Medicine. 2011; 32: p. 78–93.

Remon Jordi, Lianes Pilar, Martinez Susana, et al. Adjuvant treatment in resected non-small cell lung cancer: Current and future issues. Critical Reviews in Oncology/Hematology. 2013; xxx.

Suzanne George, Schell J Michael, C Frank. Detterbeck, Mark A. Socinski. Adjuvant Chemotherapy for resected non-small cell carcinoma of the Lung: why we still don’t know. The Oncologist. 1998;(3): p. 35–44.

Sangha Randeep, Price Julie, Butts A Charles. Adjuvant therapy in non-Small cell Lung cancer: current and future. The Oncologist. 2010;(15): p. 862–872.


  • There are currently no refbacks.

View My Stats



Creative Commons License

JR (p-ISSN: 2407-0831e-ISSN: 2621-8372) is licensed under Creative Commons Attribution-ShareAlike 4.0 International License.